Another leading industry publication, PMLive, covers CEOi launch

March 13, 2013

Pharma CEOs team up to tackle Alzheimer’s
Call for Global Alzheimer’s Action Plan to prevent and treat neurological condition by 2025
Read the full article

Why 2020?

USAgainstAlzheimer’s has retained its goal of stopping Alzheimer’s by 2020 rather than endorsing the goal of the National Plan to Address Alzheimer’s Disease that calls for preventing and effectively treating the disease by 2025. While we support the national plan and its goals, we believe, as most every family touched by Alzheimer’s disease believes, that preventing and effectively treating Alzheimer's by 2025 is simply too long a wait for concrete progress. There are promising avenues of drug discovery and development that will, if successful, deliver a means of slowing or deferring Alzheimer's symptoms by 2020. By voicing the urgency felt by so many families, we will pressure researchers and industry to do all in their power to make that happen.

Another leading industry publication, PMLive, covers CEOi launch

Stay Updated